Cluster randomized trials: Considerations for design and analysis

被引:6
|
作者
Chakraborty H. [1 ]
Lyons G. [1 ]
机构
[1] Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, 915 Green Street, Columbia, 29208, SC
关键词
Analysis; Cluster randomized trials; Intracluster correlation; Sample size estimation; Statistical design;
D O I
10.1080/15598608.2014.992081
中图分类号
学科分类号
摘要
Scientists often use randomized controlled trials to compare a newly developed treatment to the existing one, or to a placebo. Patients are randomly assigned to a treatment, and they are compared with respect to the outcome of interest. The cluster randomized trial (CRT) is a type of randomized controlled trial in which the treatments are randomized at the group, rather than individual, level. The intracluster correlation (ICC) measures the degree of similarity between individuals within clusters. CRTs can be designed in several ways; it is essential that researchers carefully plan the study, from sample size calculations to ICC calculation to analysis, in order to get valid and meaningful results. In this article we review and discuss the considerations essential to conducting a successful CRT using both frequentist and Bayesian approaches, and we discuss recent trends in CRT analysis, including highlighting new methodology for both binary and continuous data. © Grace Scientific Publishing, LLC.
引用
收藏
页码:685 / 698
页数:13
相关论文
共 50 条
  • [31] OARSI Clinical Trials Recommendations: Key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis
    Losina, E.
    Ranstam, J.
    Collins, J. E.
    Schnitzer, T. J.
    Katz, J. N.
    OSTEOARTHRITIS AND CARTILAGE, 2015, 23 (05) : 677 - 685
  • [32] Considerations in the design of randomized trials to screen for type 2 diabetes
    Echouffo-Tcheugui, Justin B.
    Prorok, Philip C.
    CLINICAL TRIALS, 2014, 11 (03) : 284 - 291
  • [33] Design and quality considerations for randomized controlled trials in systemic sclerosis
    Kyriakidi, M
    Ioannidis, JPA
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (01): : 73 - 81
  • [34] Practical considerations in utilizing cluster randomized controlled trials conducted in biopharmaceutical industry
    Fang, Yixin
    He, Weili
    CLINICAL TRIALS, 2022, 19 (04) : 416 - 421
  • [35] Multiplicity considerations in the design and analysis of clinical trials
    Cook, RJ
    Farewell, VT
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 1996, 159 : 93 - 110
  • [36] Experimental Design and Power for Moderation in Multisite Cluster Randomized Trials
    Dong, Nianbo
    Kelcey, Benjamin
    Spybrook, Jessaca
    JOURNAL OF EXPERIMENTAL EDUCATION, 2024, 92 (04): : 741 - 757
  • [37] Maximin design of cluster randomized trials with heterogeneous costs and variances
    Breukelen, Gerard J. P.
    Candel, Math J. J. M.
    BIOMETRICAL JOURNAL, 2021, 63 (07) : 1444 - 1463
  • [38] Leveraging contact network structure in the design of cluster randomized trials
    Harling, Guy
    Wang, Rui
    Onnela, Jukka-Pekka
    De Gruttola, Victor
    CLINICAL TRIALS, 2017, 14 (01) : 37 - 47
  • [39] When should matching be used in the design of cluster randomized trials?
    Chondros, Patty
    Ukoumunne, Obioha C.
    Gunn, Jane M.
    Carlin, John B.
    STATISTICS IN MEDICINE, 2021, 40 (26) : 5765 - 5778
  • [40] Two Questions About the Design of Cluster Randomized Trials: A Tutorial
    Samsa, Gregory P.
    Winger, Joseph G.
    Cox, Christopher E.
    Olsen, Maren K.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2021, 61 (04) : 858 - 863